227 related articles for article (PubMed ID: 31673101)
1. Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies.
Kita Y; Hamada A; Saito R; Teramoto Y; Tanaka R; Takano K; Nakayama K; Murakami K; Matsumoto K; Akamatsu S; Yamasaki T; Inoue T; Tabata Y; Okuno Y; Ogawa O; Kobayashi T
Br J Cancer; 2019 Dec; 121(12):1027-1038. PubMed ID: 31673101
[TBL] [Abstract][Full Text] [Related]
2. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo.
Li Z; Xie X; Tan G; Xie F; Liu N; Li W; Sun X
Biol Pharm Bull; 2021; 44(9):1323-1331. PubMed ID: 34471060
[TBL] [Abstract][Full Text] [Related]
4. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer.
Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C
Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines.
Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM
Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721
[TBL] [Abstract][Full Text] [Related]
6. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy.
Li H; Liu B; Ao H; Fu J; Wang Y; Feng Y; Guo Y; Wang X
J Nanobiotechnology; 2020 Jan; 18(1):4. PubMed ID: 31907045
[TBL] [Abstract][Full Text] [Related]
7. Intestinal microbiota regulates anti-tumor effect of disulfiram combined with Cu
Hu H; Cui L; Lu J; Wei K; Wei J; Li S; Zou C; Chen T
Cancer Med; 2020 Sep; 9(18):6791-6801. PubMed ID: 32750218
[TBL] [Abstract][Full Text] [Related]
8. Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance.
Song W; Tang Z; Shen N; Yu H; Jia Y; Zhang D; Jiang J; He C; Tian H; Chen X
J Control Release; 2016 Jun; 231():94-102. PubMed ID: 26928530
[TBL] [Abstract][Full Text] [Related]
9. Silk Fibroin-Modified Disulfiram/Zinc Oxide Nanocomposites for pH Triggered Release of Zn
Zhao YZ; Lin MT; Lan QH; Zhai YY; Xu HL; Xiao J; Kou L; Yao Q
Mol Pharm; 2020 Oct; 17(10):3857-3869. PubMed ID: 32833457
[TBL] [Abstract][Full Text] [Related]
10. Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death.
Guo F; Yang Z; Sehouli J; Kaufmann AM
Curr Oncol; 2022 Apr; 29(4):2808-2822. PubMed ID: 35448203
[TBL] [Abstract][Full Text] [Related]
11. High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Iljin K; Ketola K; Vainio P; Halonen P; Kohonen P; Fey V; Grafström RC; Perälä M; Kallioniemi O
Clin Cancer Res; 2009 Oct; 15(19):6070-8. PubMed ID: 19789329
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram enhances the antitumor activity of cisplatin by inhibiting the Fanconi anemia repair pathway.
Yuan M; Wu Q; Zhang M; Lai M; Chen W; Yang J; Jiang L; Cao J
J Zhejiang Univ Sci B; 2023 Mar; 24(3):207-220. PubMed ID: 36915997
[TBL] [Abstract][Full Text] [Related]
13. Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)
Yuan XX; Duan YF; Luo C; Li L; Yang MJ; Liu TY; Cao ZR; Huang W; Bu X; Yue X; Liu RY
Biochem Pharmacol; 2023 May; 211():115498. PubMed ID: 36913990
[TBL] [Abstract][Full Text] [Related]
14. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
15. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
16. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo.
Jivan R; Peres J; Damelin LH; Wadee R; Veale RB; Prince S; Mavri-Damelin D
Cancer Lett; 2018 Mar; 417():1-10. PubMed ID: 29274360
[TBL] [Abstract][Full Text] [Related]
18. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
19. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxic effect of disulfiram/copper on human cervical cancer cell lines and LGR5-positive cancer stem-like cells.
Cao HZ; Yang WT; Zheng PS
BMC Cancer; 2022 May; 22(1):521. PubMed ID: 35534815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]